Rosiglitazone RECORD study: glucose control outcomes at 18 months-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rosiglitazone RECORD study: glucose control outcomes at 18 months

Published:2007-05-22 Issue:6 Volume:24 Page:626-634
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

Home P. D.,Jones N. P.,Pocock S. J.,Beck-Nielsen H.,Gomis R.,Hanefeld M.,Komajda M.,Curtis P.,

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2007.02160.x/fullpdf

Reference28 articles.

1. Global guideline for Type 2 diabetes: recommendations for standard, comprehensive and minimal care;IDF Clinical Guidelines Task Force;Diabet Med,2006

2. Sulphonylurea failure in non-insulin-dependent diabetic patients over 6 years (UKPDS;Matthews;Diabet Med,1998

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

4. Glycaemic control with diet, sulphonylurea, metformin, or insulin in patients with Type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49);Turner;J Am Med Assoc,1999

5. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study;Burke;Arch Int Med,1999

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

2. Mechanisms of Nelumbinis folium targeting PPARγ for weight management: A molecular docking and molecular dynamics simulations study;Computers in Biology and Medicine;2023-11

3. Secondary Diseases of the Kidney;Evidence‐Based Nephrology;2022-11-18

4. The forgotten type 2 diabetes mellitus medicine: rosiglitazone;Diabetology International;2021-06-29

5. Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics;Postgraduate Medicine;2019-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3